EBC Financial Group reconnu « Meilleur courtier pour l’exécution des ordres » lors des Professional Trader Awards 2025 Leave a reply Cette reconnaissance fait suite à un vote des traders professionnels et actifs. Elle met en exergue le rôle essentiel de la qualité d’exécution des ordres dans le trading de qualité institutionnelle Christopher Potts, directeur des opérations […]
Month: December 2025
Senegal’s President Faye Opens MSGBC 2025 with Call for African Energy Sovereignty
Dakar: Senegalese President H.E. Bassirou Diomaye Faye opened the 2025 edition of the MSGBC Oil, Gas and Power conference and exhibition in Dakar today, setting an ambitious tone for regional integration, energy sovereignty, and shared prosperity across West Africa’s premier energy basin. Marking the fourth edition of the high-level energy gathering, the President underscored the […]
Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy
RICHARDSON, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Mavenir, the software company building AI-by-design mobile networks, today announced a strong leadership team to accelerate its vision for telco-first, cloud-native, AI-by-design networks. This transformation follows the company’s recent recapitalization and aligns with a refreshed product strategy focused on mobile core, AI-enabled automation, and cloud-native platforms. New […]
Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy
Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy Leave a reply RICHARDSON, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Mavenir, the software company building AI-by-design mobile networks, today announced a strong leadership team to accelerate its vision for telco-first, cloud-native, AI-by-design networks. This transformation […]
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12) After 12 weeks off therapy (week 25 of the study), 82% of evaluable patients (9 of 11) maintained a durable reduction in total polyp burden, […]